FDA Inspection 1004511 — Akorn, Inc.

Akorn, Inc. — FEI 3003102962

The FDA completed an inspection of Akorn, Inc. on Feb 13, 2017 in Gurnee, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 13, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gurnee, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.